Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             23 results found
no title author magazine year volume issue page(s) type
1 Analysis of redox and apoptotic effects of anthracyclines to delineate a cardioprotective strategy Fulbright, Joy Marie
2015
76 6 p. 1297-1307
article
2 Antimitotic drugs in the treatment of cancer Vuuren, Rustelle Janse van
2015
76 6 p. 1101-1112
article
3 A phase 1 study of lenvatinib, multiple receptor tyrosine kinase inhibitor, in Japanese patients with advanced solid tumors Nakamichi, Shinji
2015
76 6 p. 1153-1161
article
4 A study to explore the correlation of ABCB1, ABCG2, OCT1 genetic polymorphisms and trough level concentration with imatinib mesylate-induced thrombocytopenia in chronic myeloid leukemia patients Francis, Jose
2015
76 6 p. 1185-1189
article
5 Chemotherapy-induced neutropenia as a prognostic factor in patients with unresectable pancreatic cancer Kurihara, Tatsuya
2015
76 6 p. 1217-1224
article
6 Effect of pH adjustment by mixing steroid for venous pain in colorectal cancer patients receiving oxaliplatin through peripheral vein: a multicenter randomized phase II study (APOLLO) Hata, Taishi
2015
76 6 p. 1209-1215
article
7 Elevated preoperative plasma D-dimer level is a useful predictor of chemoresistance and poor disease outcome for serous ovarian cancer patients Liu, Ping
2015
76 6 p. 1163-1171
article
8 Erlotinib-related rhabdomyolysis: the role of pharmacogenetics and drug–drug interaction Koršić, Marta
2015
76 6 p. 1317-1319
article
9 Evaluation of the safety and pathological effects of neoadjuvant full-dose gemcitabine combination radiation therapy in patients with biliary tract cancer Kobayashi, Shogo
2015
76 6 p. 1191-1198
article
10 Evodiamine inhibits the migration and invasion of nasopharyngeal carcinoma cells in vitro via repressing MMP-2 expression Peng, Xianbing
2015
76 6 p. 1173-1184
article
11 Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells Wang, Lijun
2015
76 6 p. 1247-1257
article
12 Local transdermal therapy to the breast for breast cancer prevention and DCIS therapy: preclinical and clinical evaluation Lee, Oukseub
2015
76 6 p. 1235-1246
article
13 Low-dose capecitabine plus trastuzumab as first-line treatment in patients 75 years of age or older with HER2-positive advanced gastric cancer: a pilot study Kim, Young Saing
2015
76 6 p. 1267-1272
article
14 Oxygen carrier YQ23 can enhance the chemotherapeutic drug responses of chemoresistant esophageal tumor xenografts Lee, Nikki P.
2015
76 6 p. 1199-1207
article
15 Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors Fox, Elizabeth
2015
76 6 p. 1273-1283
article
16 Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction Deenen, Maarten J.
2015
76 6 p. 1285-1295
article
17 Phase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic cancer Wu, Zheng
2015
76 6 p. 1309-1314
article
18 Phase I study of nintedanib in combination with pemetrexed as second-line treatment of Japanese patients with advanced non-small cell lung cancer Daga, Haruko
2015
76 6 p. 1225-1233
article
19 Phase 1 study of galunisertib, a TGF-beta receptor I kinase inhibitor, in Japanese patients with advanced solid tumors Fujiwara, Yutaka
2015
76 6 p. 1143-1152
article
20 Phase 2 trial of the topoisomerase II inhibitor, amrubicin, as second-line therapy in patients with metastatic urothelial carcinoma Galsky, Matthew D.
2015
76 6 p. 1259-1265
article
21 Schedule-dependent modulation of the pharmacokinetics of MK-2206, an oral pan-AKT inhibitor: perspectives Srinivas, Nuggehally R.
2015
76 6 p. 1315-1316
article
22 Targeted therapy in cancer Tsimberidou, Apostolia-Maria
2015
76 6 p. 1113-1132
article
23 The pharmacokinetics and safety of idelalisib in subjects with severe renal impairment Jin, F.
2015
76 6 p. 1133-1141
article
                             23 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands